Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 432

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 1B
Chunk 432
---
 date fair value of $144,454 issued as partial payment of salary.

			(6) 

			Includes 207,201 restricted share units with an aggregate grant date fair value of $411,671.

			(7) 

			Represents (i) $24,000 in car allowance (ii) $3,007 in health insurance in 2025 and (i) $24,000 in car allowance and (ii) $1,741 in health insurance in 2024. All compensation to Dr. Brooks was paid in Canadian dollars and was converted from US dollars using the average foreign exchange rate for each bi-weekly pay period of the year from oanda.com.

			(8) 

			Mr. Weiler was appointed Chief Financial Officer, effective May 1, 2025.

			(9) 

			Includes 65,000 restricted share units with an aggregate grant date fair value of $129,143.

			(10) 

			Represents (i) $10,000 in car allowance (ii) $558 in health insurance in 2025. All compensation to Mr. Weiler was paid in Canadian dollars and was converted from US dollars using the average foreign exchange rate for each bi-weekly pay period of the year from oanda.com.

			(11) 

			Mr. Lemieux served as Chief Financial Officer through May 1, 2025.

			(12) 

			Includes 56,300 restricted share units with an aggregate grant date fair value of $111,858.

			(13) 

			Represents (i) $14,000 in car allowance (ii) $18,054 in consulting fees for services following Mr. Lemieux's tenure as Chief Financial Officer in 2025 and $24,000 in car allowance in 2024. All compensation to Mr. Lemieux was paid in Canadian dollars and was converted from US dollars using the average foreign exchange rate for the year from oanda.com.

55

Narrative Disclosure to Summary Compensation Table Employment Agreements 

Amended and Restated Employment Agreement with Pardeep Nijhawan effective as of August 4, 2023, as amended December 7, 2023

On August 4, 2023, the Company entered into an amended and restated employment agreement with Pardeep Nijhawan, the Company’s Chief Executive Officer that superseded prior